RESULTS: PET/CT scan findings at the time of diagnosis MaxSUV1 10.8±1.1; MaxParenhim1 2.2±0.4; MaxLymphN1 8.3±1.1. MaxSUV1 were correlated with X-ray score-1 (r=0.369, p=0.001; with sACE (r=0.266, p=0.017) with CTO (r=0.483, p=0.000). MaxSUV2 was 6.2±1.1 in whole group without correlations with markers except X-ray score-2 (p=0.055). Correlations with MaxSUV2 were only present in the group with antifungal therapy (CTO2, r=0.509, p=0.003) and X-ray score-2 (r=0.533, p=0.001). In the group without therapy and follow-up without therapy, MaxSUV2 correlated with X-ray score-2 (r=0.567, p=0.014). No correlations were found between first and second PET/CT scan and pulmonary function tests.